Properties of HIV-1 associated cholesterol in addition to raft formation are important for virus infection

Virus Research

Volumn 210, Issue , 2015, Pages 18-21

  Hawkes, David ^a   Jones, Kate L ^a   Smyth, Redmond P ^a   Pereira, Cândida F ^a   Bittman, Robert ^b   Jaworowski, Anthony ^a   Mak, Johnson ^a,c,d  

^a BURNET INSTITUTE   (Australia)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c DEAKIN UNIVERSITY   (Australia)

^d CSIRO   (Australia)

Author keywords

Cholesterol; HIV; Lipid rafts; Viral entry; Virion membrane

Indexed keywords

CARBON; CHOLESTEROL; CHOLESTEROL DERIVATIVE;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; LIPID MEMBRANE; LIPID RAFT; MEMBRANE FLUIDITY; MEMBRANE STRUCTURE; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS REPLICATION; CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY; VIRUS ENTRY;

CHOLESTEROL; HIV-1; HUMANS; VIRUS INTERNALIZATION;

EID: 84947814731     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.06.023     Document Type: Article

References (43)

1. Aloia R.C., Jensen F.C., Curtain C.C., Mobley P.W., Gordon L.M. Lipid composition and fluidity of the human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:900-904.
2. Aloia R.C., Tian H., Jensen F.C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:5181-5185.
3. Brown D.A., London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 2000, 275:17221-17224.
4. Brugger B., Glass B., Haberkant P., Leibrecht I., Wieland F.T., Krausslich H.G. The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2641-2646.
5. Campbell S.M., Crowe S.M., Mak J. Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J. Clin. Virol. 2001, 22:217-227.
6. Campbell S.M., Crowe S.M., Mak J. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS 2002, 16:2253-2261.
7. Campbell S., Gaus K., Bittman R., Jessup W., Crowe S., Mak J. The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity. J. Virol. 2004, 78:10556-10565.
8. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess J.W., Sowder R.C., 2nd, Barsov E., Hood B.L., Fisher R.J., Nagashima K., Conrads T.P., Veenstra T.D., Lifson J.D., Ott D.E. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 2006, 80:9039-9052.
9. Chojnacki J., Staudt T., Glass B., Bingen P., Engelhardt J., Anders M., Schneider J., Muller B., Hell S.W., Krausslich H.G. Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy. Science 2012, 338:524-528.
10. Chukkapalli V., Hogue I.B., Boyko V., Hu W.S., Ono A. Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding. J. Virol. 2007, 82:2405-2417.
11. Chukkapalli V., Oh S.J., Ono A. Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:1600-1605.
12. Graham D.R., Chertova E., Hilburn J.M., Arthur L.O., Hildreth J.E. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. J. Virol. 2003, 77:8237-8248.
13. Hawkes D.J., Mak J. Lipid membrane; a novel target for viral and bacterial pathogens. Curr. Drug Targets 2006, 7:1615-1621.
14. Jones K.L., Sonza S., Mak J. Primary T-lymphocytes rescue the replication of HIV-1 DIS RNA mutants in part by facilitating reverse transcription. Nucleic Acids Res. 2008, 36:1578-1588.
15. Jones K.L., Roche M., Gantier M.P., Begum N.A., Honjo T., Caradonna S., Williams B.R., Mak J. X4 and R5HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells. J. Biol. Chem. 2010, 285:18603-18614.
16. Jones K.L., Karpala A., Hirst B., Jenkins K., Tizard M., Pereira C.F., Leis A., Monaghan P., Hyatt A., Mak J. Visualising single molecules of HIV-1 and miRNA nucleic acids. BMC Cell Biol. 2013, 14:21.
17. Liao Z., Cimakasky L.M., Hampton R., Nguyen D.H., Hildreth J.E. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retroviruses 2001, 17:1009-1019.
18. Liao Z., Graham D.R., Hildreth J.E. Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. AIDS Res. Hum. Retroviruses 2003, 19:675-687.
19. Lorizate M., Sachsenheimer T., Glass B., Habermann A., Gerl M.J., Krausslich H.G., Brugger B. Comparative lipidomics analysis of HIV-1 particles and their producer cell membrane in different cell lines. Cell Microbiol. 2013, 15:292-304.
20. Manes S., del Real G., Martinez A.C. Pathogens: raft hijackers. Nat. Rev. Immunol. 2003, 3:557-568.
21. Mattjus P., Bittman R., Vilcheze C., Slotte J.P. Lateral domain formation in cholesterol/phospholipid monolayers as affected by the sterol side chain conformation. Biochim. Biophys. Acta 1995, 1240:237-247.
22. Nguyen D.H., Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 2000, 74:3264-3272.
23. Ono A., Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13925-13930.
24. Ono A., Freed E.O. Role of lipid rafts in virus replication. Adv. Virus Res. 2005, 64:311-358.
25. Ono A., Ablan S.D., Lockett S.J., Nagashima K., Freed E.O. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:14889-14894.
26. Ono A., Waheed A.A., Freed E.O. Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag. Virology 2007, 360:27-35.
27. Richieri S.P., Bartholomew R., Aloia R.C., Savary J., Gore R., Holt J., Ferre F., Musil R., Tian H.R., Trauger R., Lowry P., Jensen F., Carlo D.J., Maigetter R.Z., Prior C.P. Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography. Vaccine 1998, 16:119-129.
28. Saad J.S., Miller J., Tai J., Kim A., Ghanam R.H., Summers M.F. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:11364-11369.
29. Saad J.S., Loeliger E., Luncsford P., Liriano M., Tai J., Kim A., Miller J., Joshi A., Freed E.O., Summers M.F. Point mutations in the HIV-1 matrix protein turn off the myristyl switch. J. Mol. Biol. 2007, 366:574-585.
30. Simons K., Gerl M.J. Revitalizing membrane rafts: new tools and insights. Nat. Rev. Mol. Cell. Biol. 2010, 11:688-699.
31. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
32. Simons K., Sampaio J.L. Membrane organization and lipid rafts. Cold Spring Harb. Perspect. Biol. 2011, 3:a004697.
33. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1:31-41.
34. Sundquist W.I., Krausslich H.G. HIV-1 assembly, budding, and maturation. Cold Spring Harb. Perspect. Med. 2012, 2:a006924.
35. Vilcheze C., McMullen T.P., McElhaney R.N., Bittman R. The effect of side-chain analogues of cholesterol on the thermotropic phase behavior of 1-stearoyl-2-oleoylphosphatidylcholine bilayers: a differential scanning calorimetric study. Biochim. Biophys. Acta 1996, 1279:235-242.
36. Waheed A.A., Freed E.O. The role of lipids in retrovirus replication. Viruses 2010, 2:1146-1180.
37. Waheed A.A., Ablan S.D., Mankowski M.K., Cummins J.E., Ptak R.G., Schaffner C.P., Freed E.O. Inhibition of HIV-1 replication by amphotericin B methyl ester: selection for resistant variants. J. Biol. Chem. 2006, 281:28699-28711.
38. Waheed A.A., Ablan S.D., Roser J.D., Sowder R.C., Schaffner C.P., Chertova E., Freed E.O. HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:8467-8471.
39. Waheed A.A., Ablan S.D., Soheilian F., Nagashima K., Ono A., Schaffner C.P., Freed E.O. Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence. J. Virol. 2008, 82:9776-9781.
40. Waheed A.A., Ablan S.D., Sowder R.C., Roser J.D., Schaffner C.P., Chertova E., Freed E.O. Effect of mutations in the human immunodeficiency virus type 1 protease on cleavage of the gp41 cytoplasmic tail. J. Virol. 2009, 84:3121-3126.
41. Yang S.T., Kiessling V., Simmons J.A., White J.M., Tamm L.K. HIV gp41-mediated membrane fusion occurs at edges of cholesterol-rich lipid domains. Nat. Chem. Biol. 2015, 11:424-431.
42. Zack J.A., Haislip A.M., Krogstad P., Chen I.S. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 1992, 66:1717-1725.
43. van Til N.P., Heutinck K.M., van der Rijt R., Paulusma C.C., van Wijland M., Markusic D.M., Elferink R.P., Seppen J. Alteration of viral lipid composition by expression of the phospholipid floppase ABCB4 reduces HIV vector infectivity. Retrovirology 2008, 5:14.